Evidence map›Paper›PMID 35284069›Full record

ReviewAnnals of medicine and surgery (2012)2022

Symptomatology, prognosis and clinical findings of STEMI as a ramification of COVID-19: A systematic review and proportion meta-analysis.

Vikash Jaiswal, Talal Almas, Song Peng Ang, David Song, Nishat Shama, Tatyana Storozhenko, Kriti Lnu, Garima Parmar, Saria Qaiser, Sidra Naz and 2 more

Open access · diamondAbstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 11 institutions in 8 countries.

Vikash JaiswalAMA School of Medicine, Makati, Philippines.
Talal AlmasRoyal College of Surgeons in Ireland, Dublin, Ireland.
Song Peng AngInternational Medical University, Malaysia.
David SongIcahn School of Medicine at Mount Sinai, NY, USA.
Nishat ShamaBangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, Dhaka, Bangladesh.
Tatyana StorozhenkoGovernment Institution "L.T. Malaya Therapy National Institute NAMSU," Kharkiv, Ukraine.
Kriti LnuDepartment of Internal Medicine, UPMC Harrisburg, USA.
Garima ParmarKasturba Medical College Mangalore, India.
Saria QaiserRawalpindi Medical University, Punjab, Pakistan.
Sidra NazHarvard Medical School, Boston, MA, USA.
Akash JaiswalDepartment of Geriatric Medicine, All India Institute of Medical Science, New Delhi, India.
Jahanzeb MalikDepartment of Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan.
Rawalpindi Medical University · PKAll India Institute of Medical Sciences · INAMA Computer University · PHBangladesh Institute of Research and Rehabilitation for Diabetes Endocrine and Metabolic Disorders · BDHarvard University · USIcahn School of Medicine at Mount Sinai · USInternational Medical University · MYKasturba Medical College, MangaloreL.T. Malaya National Therapy Institute of the National Academy of Medical Sciences of Ukraine · UARoyal College of Surgeons in Ireland · IEUPMC Central Pa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is an increasing COVID-19 population with concurrent STEMI. SARS-CoV-2 poses a significant risk of hypercoagulable and/or prothrombotic events due to the disturbance in hemostasis by affecting all three components of the Virchow's triad. These abnormalities in hemostasis are an increased risk factor for cardiovascular events, including acute thrombotic occlusion of coronary arteries leading to myocardial infarction. Objective: The objective of this study is to collate the prognosis, symptomatology and clinical findings of COVID-19 adverse events causing STEMI. Methods: Databases were queried with various keyword combinations to find applicable articles. Cardiovascular risk factors, symptomatology, mortality and rates of PCI were analyzed using random-effect model. Results: 15 studies with a total of 379 patients were included in the final analysis. Mean age of patients was 62.82 ± 36.01, with a male predominance (72%, n = 274). Hypertension, dyslipidemia and diabetes mellitus were the most common cardiovascular risk factors among these patients, with a pooled proportion of 72%, 59% and 40% respectively. Dyspnea (61%, n = 131) was the most frequent presenting symptom, followed by chest pain (60%, n = 101) and fever (56%, n = 104). 62% of the patients had obstructive CAD during coronary angiography. The primary reperfusion method used in the majority of cases was percutaneous coronary intervention (64%, n = 124). Mortality, which is the primary outcome in our study, was relatively high, with a rate of 34% across studies. Conclusion: Our findings show that most cases have been found in males, while the most common risk factors were Hypertension and Diabetes Mellitus. In most COVID-19 cases with ST-segment myocardial infarction, most hospitalized patients underwent primary percutaneous coronary intervention instead of fibrinolysis. The in-hospital mortality was significantly higher, making this report significant. As the sample size and reported study are considerably less, it warrants a further large-scale investigation to generalize it.

Indexed as

Cardiovascular diseaseCOVID-19MortalityST-Segment myocardial infarction

Identifiers

PMID35284069
PMCPMC8902059
OpenAlexW4221017361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.